0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThis study provides real-world evidence that lenvatinib confers superior overall survival over sorafenib in recurrent HCC post-LT, with manageable toxicity. As LT indications expand, these findings support lenvatinib as a preferred first-line treatment. Further prospective studies are needed to confirm these results and optimize post-LT treatment strategies.
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, Caterina Vivaldi, Masatoshi Kudo, Shigeo Shimose, Goki Suda, Silvia Camera, Silvia Foti, Mario Domenico Rizzato, Francesca Salani, Naoshi Nishida, Tomotake Shirono, Naoya Sakamoto, Laura Passeri, Michele Ferrara, Caterina Soldà, Silvia Cesario, Kazuomi Ueshima, Takashi Niizeki, Takuya Sho, Mara Persano, Francesco Vitiello, Federica Invernizzi, Sara Lonardi, Gianluca Masi, Margherita Rimini, Andrea Casadei‐Gardini (2025). Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study. , 56(3), DOI: https://doi.org/10.1111/hepr.70076.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2025
Authors
28
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1111/hepr.70076
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
